Search | Caixin

GO

Sort by: Newest
Newest Relevance Oldest
Type: All
All News CX Tech Videos Podcast Gallery In-depth
Time: Any Time
Any time Past 24 Hours Past Week Past Month Past Year Custom Range
Range: All
All Headline Byline Full Text

Reset

Showing search results for wang lijun

Sinopharm’s Vaccine Nears Emergency-Use Approval by WHO
China Reports More Than 1,700 Deaths From Adverse Medical Reactions in 2020

. Contact reporter Wang Xintong (xintongwang@caixin.com) and editor Lu Zhenhua (zhenhualu@caixin.com
Sinovac Covid Shot 50.7% Effective, Brazilian Paper Shows

quarter of the population, in the first half of the year. Contact reporter Wang Xintong
Vaccine Startup Clover Biopharma Raises $230 Million in Financing
In Depth: Why Vaccines Won’t Soon End the Covid-19 Pandemic

coexist with the virus,” one immunologist said. Wang Zhuoqing and Xiao Zhongxian contributed to this
CanSino’s Covid-19 Vaccine Wins Mexico Approval for Emergency Use
BioNTech Says It’s On Track to Supply 100 Million Vaccine Doses to China
Cover Story: Can the Virus Still Win?

said. Wang Zhuoqing and Hao Tianqi contributed to this story. Contact reporter Han Wei
Sinovac Applies for Conditional Approval of Covid-19 Vaccine in China
Leading Chinese Drug Researcher Calls for Greater Transparency on China Vaccines

OR